← Insider buys
CUE

Cue Biopharma, Inc. · Healthcare

Director Christopher A Marlett sold $402K of Cue Biopharma, Inc.

Sold$402,209
$16.28Price
24,700Shares
−3%Stake

What CUE did after the filing

Prices for CUE after this filing aren't in yet.

Traded Fri, Dec 27. Filed Tue, Dec 31, 6:26 PM ET, after the close. Not investment advice.